It’s time hospitals stop stealing drug discounts from poor patients and taxpayers

The 340B drug discount program, intended to help hospitals serving low-income patients, has become controversial as larger hospitals exploit it to gain significant drug discounts at the expense of taxpayers and low-income patients. This practice diverts funds meant for patient care, ultimately burdening taxpayers who fund these discounts through Medicare and Medicaid. Critics argue it's time for reform to ensure these savings go directly to those who need them most, highlighting the urgent need to balance hospital profits with fair healthcare access.